Northwest Biotherapeutics reported $6.2M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agenus USD 78.81M 16.47M Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Celldex Therapeutics USD 724.93M 265.71M Jun/2026
Eisai JPY 883.01B 121.38B Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Northwest Biotherapeutics USD 6.2M 996K Mar/2026
Pfizer USD 41.36B 1.46B Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026